K.J. Harrison & Partners’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-20,000
Closed -$160K 279
2020
Q3
$160K Hold
20,000
0.03% 208
2020
Q2
$200K Buy
+20,000
New +$200K 0.05% 179